 |
|
Tumor Immunology and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
Chi Young Jung, Scott J. Antonia
Tuberc Respir Dis. 2018;81(1):29-41. Published online 2017 Dec 29 DOI: https://doi.org/10.4046/trd.2017.0120
|
|
Citations to this article as recorded by
 Correlation between PD-L1 expression status and efficacy of immunotherapy as second-line or later-line therapy in advanced non-small cell lung cancer patients
Jingya Liu, Yingchun Man, Jianing Gao, Xinxin Wang, Lijie Zhang, Mingheng Li, Jiahan Yu
European Journal of Cancer Prevention.2024;[Epub] CrossRef An exosome mRNA-related gene risk model to evaluate the tumor microenvironment and predict prognosis in hepatocellular carcinoma
Zhonghai Du, Xiuchen Han, Liping Zhu, Li Li, Leandro Castellano, Justin Stebbing, Ling Peng, Zhiqiang Wang
BMC Medical Genomics.2024;[Epub] CrossRef Cancer immunotherapeutic effect of carboxymethylated β-d-glucan coupled with iron oxide nanoparticles via reprogramming tumor-associated macrophages
Yuting Su, Fan Yang, Mingfu Wang, Peter C.K. Cheung
International Journal of Biological Macromolecules.2023; 228: 692. CrossRef Echinocystic acid induces the apoptosis, and inhibits the migration and invasion of non-small cell lung cancer cells
Duojie Zhu, Bin Li, Cheng Wang, Peng Jiang, Futian Tang, Yumin Li
Medical Oncology.2023;[Epub] CrossRef Research progress on the GRP78 gene in the diagnosis, treatment and immunity of cervical cancer
Yingying Bai, Wenhua Wang, Yuemei Cheng, Yongxiu Yang
European Journal of Medical Research.2023;[Epub] CrossRef Understanding the feasibility of chemotherapeutic and immunotherapeutic targets against non-small cell lung cancers: an update of resistant responses and recent combinatorial therapies
Parth Malik, Ruma Rani, Raghu Solanki, Vishal Haribhai Patel, Tapan Kumar Mukherjee
Exploration of Targeted Anti-tumor Therapy.2023; : 850. CrossRef Perioperative immunotherapy in stage IB-III non-small cell lung cancer: a critical review of its rationale and considerations
Jae Kyeom Sim, Juwhan Choi, Sung Yong Lee
The Korean Journal of Internal Medicine.2023; 38(6): 787. CrossRef Oncolytic Vaccinia Virus in Lung Cancer Vaccines
Cao-Sang Truong, So Young Yoo
Vaccines.2022; 10(2): 240. CrossRef Safety and efficacy of mutant neoantigen-specific T-cell treatment combined anti-PD-1 therapy in stage IV solid tumors
Qi Song, Bo Yang, Wei Sheng, Zishan Zhou, Tianfu Zhang, Boyu Qin, Liyan Ji, Pansong Li, Dan Wang, Xiaoling Zhang, Shengjie Sun, Guoqing Zhang, Xiao Zhao, Quan Gan, Qi Xiong, Yanfang Guan, Xuefeng Xia, Xin Yi, Xiudi Chen, Wei Guo, Shunchang Jiao
Immunotherapy.2022; 14(7): 553. CrossRef Toxicity profile of treatment with PD-1 inhibitors for lung cancer, melanoma and renal cell carcinoma: A real-world Brazilian study
Hugo S. Duarte, Cassia R.P. Veiga, Claudimar P. Veiga, Alberto J.A. Wainstein, Ana P. Drummond-Lage
International Immunopharmacology.2022; 108: 108727. CrossRef Recent Trends of Lung Cancer in Korea
Jae Guk Lee, Ho Cheol Kim, Chang-Min Choi
Tuberculosis and Respiratory Diseases.2021; 84(2): 89. CrossRef Hsp70 in Liquid Biopsies—A Tumor-Specific Biomarker for Detection and Response Monitoring in Cancer
Caroline Werner, Stefan Stangl, Lukas Salvermoser, Melissa Schwab, Maxim Shevtsov, Alexia Xanthopoulos, Fei Wang, Ali Bashiri Dezfouli, Dennis Thölke, Christian Ostheimer, Daniel Medenwald, Martin Windberg, Matthias Bache, Martin Schlapschy, Arne Skerra,
Cancers.2021; 13(15): 3706. CrossRef Current Status of Immunotherapy for Lung Cancer and Future Perspectives
Ho Cheol Kim, Chang-Min Choi
Tuberculosis and Respiratory Diseases.2020; 83(1): 14. CrossRef Cancer immunotherapy through the prism of adaptation: Will Achilles catch the tortoise?
Igor Y. Malyshev, Larisa V. Kuznetsova, Stefania Mardente
Medical Hypotheses.2020; 137: 109545. CrossRef Recent advances in diagnostic technologies in lung cancer
Hye Jung Park, Sang Hoon Lee, Yoon Soo Chang
The Korean Journal of Internal Medicine.2020; 35(2): 257. CrossRef Risk factors for primary lung cancer among never-smoking women in South Korea: a retrospective nationwide population-based cohort study
Yoon Ho Ko, Seung Joon Kim, Wan-Seop Kim, Chan Kwon Park, Cheol-Kyu Park, Yang-Gun Suh, Jung Seop Eom, Sukki Cho, Jae Young Hur, Sung Ho Hwang, Jun-Pyo Myong
The Korean Journal of Internal Medicine.2020; 35(3): 692. CrossRef Molecular and Immune Characteristics for Lung Adenocarcinoma Patients With ERLIN2 Overexpression
Yifei Liu, Pengfei Xie, Daishang Jiang, Jian Liu, Jianguo Zhang, Tingting Bian, Jiahai Shi
Frontiers in Immunology.2020;[Epub] CrossRef Hypoxia-induced cancer stemness acquisition is associated with CXCR4 activation by its aberrant promoter demethylation
Nahyeon Kang, Su Yeon Choi, Bit Na Kim, Chang Dong Yeo, Chan Kwon Park, Young Kyoon Kim, Tae-Jung Kim, Seong-Beom Lee, Sug Hyung Lee, Jong Y. Park, Mi Sun Park, Hyeon Woo Yim, Seung Joon Kim
BMC Cancer.2019;[Epub] CrossRef Immunotherapy for non-small cell lung cancer
Sam Vafadar
JAAPA.2019; 32(9): 37. CrossRef Endoplasmic reticulum stress enhances the antigen-specific T cell immune responses and therapeutic antitumor effects generated by therapeutic HPV vaccines
Sung Yong Lee, Jee Youn Oh, Tae Heung Kang, Hyun Seock Shin, Max A. Cheng, Emily Farmer, T.-C. Wu, Chien-Fu Hung
Journal of Biomedical Science.2019;[Epub] CrossRef HDGF and PRKCA upregulation is associated with a poor prognosis in patients with lung adenocarcinoma
Honghong Jiang, Qiaofen Fu, Xin Song, Chunlei Ge, Ruilei Li, Zhen Li, Baozhen Zeng, Chunyan Li, Ying Wang, Yuanbo Xue, Rongcheng Luo, Weiyi Fang
Oncology Letters.2019;[Epub] CrossRef
|